US Stock MarketDetailed Quotes
CODX Co-diagnostics
- 1.060
- -0.040-3.64%
Close Nov 15 16:00 ET
- 1.060
- 0.000-0.03%
Post 19:54 ET
33.85MMarket Cap-768P/E (TTM)
1.110High1.050Low126.03KVolume1.100Open1.100Pre Close134.68KTurnover0.42%Turnover RatioLossP/E (Static)31.93MShares2.23052wk High0.53P/B32.02MFloat Cap1.00052wk Low--Dividend TTM30.21MShs Float30.990Historical High--Div YieldTTM5.46%Amplitude0.694Historical Low1.068Avg Price1Lot Size
About Co-diagnostics Company
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolCODX
Company NameCo-diagnostics
Listing DateJul 12, 2017
Issue Price6.00
Founded2013
CEOMr. Dwight H Egan
MarketNASDAQ
Employees155
Fiscal Year Ends12-31
Address2401 South Foothill Drive,Suite D
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84109
Phone1-801-438-1036
Websitehttp://www.codiagnostics.com
Company Executives
- Name
- Position
- Salary
- Dwight H Egan
- Chief Executive Officer and Chairman of the Board
- 1.26M
- Brian L. Brown
- Secretary, Chief Financial Officer and Principal Accounting Officer
- 1.04M
- Richard Abbott
- President
- --
- Edward L. Murphy
- Independent Director
- 298.00K
- Dr. Eugene Durenard, Pd.D
- Independent Director
- 298.00K
- Richard S. Serbin
- Independent Director
- 298.00K
- James B. Nelson
- Independent Director
- 298.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
